Trial Profile
Temocillin use in intensive care units: A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2015
Price :
$35
*
At a glance
- Drugs Temocillin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 16 Nov 2015 Status changed from recruiting to completed.
- 16 Sep 2014 New trial record